| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 66,815 | $2,405,340 | $36.00 | 05 May 2023 | Direct |
| ADC Therapeutics SA | Director | Common Shares | 106,902 | $382,709 | $3.58 | 13 Jun 2025 | Direct |
| HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 11,371 | $157,716 | $13.87 | 05 May 2023 | Direct |
| Aprea Therapeutics, Inc. | Director | Common Stock | 1,045 | $1,692 | $1.62 | 05 Jun 2025 | Direct |
| Aprea Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 4,185 | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ADCT | ADC Therapeutics SA | 13 Jun 2025 | 1 | -$45,108 | 4 | Director | 17 Jun 2025, 17:00 |
| APRE | Aprea Therapeutics, Inc. | 05 Jun 2025 | 2 | $0 | 4 | Director | 09 Jun 2025, 16:01 |
| ADCT | ADC Therapeutics SA | 03 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 17:09 |
| ADCT | ADC Therapeutics SA | 17 Jun 2024 | 1 | -$20,216 | 4 | Director | 18 Jun 2024, 21:43 |
| ADCT | ADC Therapeutics SA | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 17:44 |
| ADCT | ADC Therapeutics SA | 02 Jan 2024 | 0 | $0 | 3 | Director | 02 Jan 2024, 20:07 |
| APRE | Aprea Therapeutics, Inc. | 23 Aug 2023 | 1 | $0 | 4 | Director | 24 Aug 2023, 21:47 |
| APRE | Aprea Therapeutics, Inc. | 23 Aug 2023 | 0 | $0 | 3 | Director | 24 Aug 2023, 21:45 |
| HALO | HALOZYME THERAPEUTICS, INC. | 05 May 2023 | 2 | $0 | 4 | Director | 09 May 2023, 18:09 |
| HALO | HALOZYME THERAPEUTICS, INC. | 05 May 2022 | 1 | $0 | 4 | Director | 06 May 2022, 20:04 |
| HALO | HALOZYME THERAPEUTICS, INC. | 25 Aug 2021 | 1 | -$1,435,455 | 4 | Director | 25 Aug 2021, 17:54 |